Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Morgan Stanley (NYSE: MS) SEC filings page on Stock Titan brings together the firm’s regulatory disclosures, including current reports on Form 8‑K and other registered securities information. These filings show how Morgan Stanley communicates material events such as quarterly and annual financial results, capital actions, regulatory capital developments and securities offerings.
Form 8‑K filings frequently cover the release of financial information for specific quarters and for the full year, with press releases and financial data supplements filed as exhibits. Other 8‑K reports describe changes in the firm’s Stress Capital Buffer under the Federal Reserve’s supervisory stress testing framework, providing context on Morgan Stanley’s U.S. Basel III Standardized Approach Common Equity Tier 1 capital requirements.
The filings also list the securities registered under Section 12(b) of the Securities Exchange Act of 1934, including common stock, multiple series of non‑cumulative preferred stock represented by depositary shares, and global medium‑term notes issued by Morgan Stanley or Morgan Stanley Finance LLC, with Morgan Stanley acting as guarantor for certain notes. Additional 8‑K filings describe the approval of forms of master notes for global medium‑term notes and related legal opinions and consents.
On Stock Titan, these SEC documents are updated as they are made available on EDGAR. AI‑powered summaries help explain the key points in lengthy filings, so users can quickly see what each 8‑K, 10‑K or 10‑Q addresses without reading every page. Investors can also use this page to monitor registered securities, preferred stock disclosures and other regulatory information related to Morgan Stanley.
Morgan Stanley Finance has announced Contingent Income Memory Buffered Auto-Callable Securities linked to the S&P U.S. Equity Momentum 40% VT 4% Decrement Index (SPUMP40), due August 5, 2030. Key features include:
- Contingent Coupon Rate: 11.25% to 12.25% per annum with memory feature
- Auto-Call Feature: Monthly redemption after 6 months if index closes at or above 100% of initial level
- Downside Protection: 15% buffer (85% maximum loss)
- Coupon Barrier: 65% of initial level
The securities, priced at an estimated value of $938.90, offer conditional monthly payments but no participation in index appreciation. Notable risks include credit risk of Morgan Stanley, early redemption risk, and the underlier's limited operating history since March 2022. The 4% annual decrement feature will impact index performance regardless of market direction. These securities are not listed on any exchange, limiting secondary market trading opportunities.
Morgan Stanley Finance has announced Worst-of SPX, NDX and RTY Trigger PLUS securities due August 5, 2030. These structured notes offer leveraged exposure to the worst-performing index among the S&P 500, Nasdaq-100, and Russell 2000 indices.
Key features include:
- Maximum payment at maturity: 176% to 181% of principal ($1,760 to $1,810 per security)
- Leverage factor: 400%
- Downside threshold: 70% of initial level
- Estimated value: $944.10 per security
Notable risks include no principal protection, limited appreciation potential, and exposure to the worst-performing index. The securities don't pay interest and are subject to Morgan Stanley's credit risk. The payment at maturity will be determined solely by the worst-performing underlier's value on July 31, 2030. If any underlier declines more than 30% from its initial level, investors will be fully exposed to the downside of the worst performer.
Morgan Stanley Finance has announced SX5E Market-Linked Notes due August 5, 2030, offering investors exposure to the EURO STOXX 50® Index with enhanced upside potential. Key features include:
- A 130% to 135% participation rate in the index's positive performance
- Principal protection against negative index performance
- Estimated value of $952.00 per note
- 5-year maturity with observation date on July 31, 2030
The notes' payment structure offers asymmetric returns: investors receive 130-135% of any positive index performance while being protected against losses, maintaining the $1,000 principal even if the index declines. Notable risks include credit risk of Morgan Stanley, no interim interest payments, and limited secondary market liquidity. The notes are guaranteed by Morgan Stanley and will trade under CUSIP 61778NAV3.
Morgan Stanley Finance LLC, guaranteed by Morgan Stanley, plans to issue market-linked notes tied to the EURO STOXX 50 Index (SX5E). The notes offer 114%-119% upside participation on any positive index performance observed on July 31 2029, with full principal repayment at maturity even if the index declines. Key terms include a $1,000 face value, pricing on July 31 2025, and maturity on August 3 2029 (4-year term). The preliminary estimated value is $958.80 (≈95.9% of face), reflecting issuance and hedging costs.
Key structural features
- No periodic coupons; all return realized at maturity.
- Amount payable depends solely on index level at the single observation date; interim movements are irrelevant.
- Notes will not be listed, and secondary liquidity may be limited.
- Credit exposure to Morgan Stanley; MS Finance LLC is a wholly owned funding vehicle without independent assets.
Principal risk highlights
- Investors may earn only principal if SX5E is flat or negative.
- The 4.1% issue-price premium versus estimated value creates negative yield if held to maturity without index appreciation.
- Market value can be volatile, influenced by MS credit spreads and trading in related instruments.
- Investors may incur taxable income annually under U.S. OID rules.
Overall, the product suits investors seeking European equity exposure with principal protection and are comfortable with MS credit risk and the lack of interim income.
Morgan Stanley Finance has announced Market-Linked Notes due August 5, 2030, tied to the S&P 500® Futures Excess Return Index (SPXFP). Key features include:
- Participation rate of 128% to 133% in the index's positive performance
- Principal protection against negative index performance
- Estimated value of $954.30 per note
- 5-year maturity (2025-2030)
The notes offer enhanced upside potential while maintaining principal protection, with payments at maturity ranging from $1,000 (minimum) to potentially higher returns based on index performance. For example, a 40% index increase would yield a 51.2% return (at 128% participation rate).
Key risks include credit risk of Morgan Stanley, no interest payments, limited secondary market trading, and potential tax implications prior to maturity. The notes' value may be affected by market factors, and the final payment depends solely on the index's performance at maturity.
Morgan Stanley Finance LLC announces Worst-of SPX and SX5E Dual Directional Buffered PLUS securities due August 5, 2030. Key features include:
- Underliers: S&P 500® Index (SPX) and EURO STOXX 50® Index (SX5E)
- Leverage factor: 212% to 227%
- Buffer amount: 20% with 80% maximum loss
- Absolute return participation rate: 50%
- Estimated value: $953.00 per security (±$55.00)
The payment at maturity will be based on the worst-performing underlier's performance. Notable risks include: no interest payments, exposure to both indices' price risks, credit risk of Morgan Stanley, and limited secondary market trading. The security offers leveraged upside potential with some downside protection through the buffer, making it suitable for investors seeking enhanced returns while accepting some market risk.
Morgan Stanley Finance has announced URA Buffered Jump Securities due August 13, 2026, linked to the Global X Uranium ETF (URA). Key features include:
- Fixed upside payment of $132.50 per security (13.25% return) if the underlier is flat or up at maturity
- 25% downside buffer protecting against first 25% of losses
- Maximum loss capped at 75% of principal
- Estimated value of $965.30 per security
The securities offer conditional downside protection while maintaining upside potential in the uranium sector. Notable risks include: credit risk of Morgan Stanley, limited appreciation potential, no interim payments, and market price influenced by unpredictable factors. The product particularly targets investors seeking exposure to the uranium sector with partial downside protection.
Morgan Stanley Finance LLC has announced SPX Market-Linked Notes due January 16, 2030, offering investors exposure to S&P 500® Index performance with principal protection. Key features include:
- 100% participation rate in index gains up to a maximum payment of $1,400 per note (140% of principal)
- Principal protection against market downside - minimum payment of $1,000 per note regardless of index performance
- Notes are priced at $973.90 estimated value per note
- 4.5-year term from July 11, 2025 pricing date to January 16, 2030 maturity
Key risks include: no interest payments, limited upside potential due to payment cap, credit risk of Morgan Stanley, limited secondary market liquidity, and potential required tax recognition before maturity. The notes' value will be determined solely by the S&P 500® Index level on the January 11, 2030 observation date.
FAQ
What is the current stock price of Morgan Stanley (MS)?
What is the market cap of Morgan Stanley (MS)?
